Intensity Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INTS and other ETFs, options, and stocks.About INTS
Intensity Therapeutics, Inc. operates as biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine.
CEOLewis H. Bender
CEOLewis H. Bender
Employees16
Employees16
HeadquartersShelton, Connecticut
HeadquartersShelton, Connecticut
Founded2012
Founded2012
Employees16
Employees16
INTS Key Statistics
Market cap7.56M
Market cap7.56M
Price-Earnings ratio-0.39
Price-Earnings ratio-0.39
Dividend yield—
Dividend yield—
Average volume293.92K
Average volume293.92K
High today$0.43
High today$0.43
Low today$0.3724
Low today$0.3724
Open price$0.43
Open price$0.43
Volume435.71K
Volume435.71K
52 Week high$5.10
52 Week high$5.10
52 Week low$0.32
52 Week low$0.32
People also own
Based on the portfolios of people who own INTS. This list is generated using Robinhood data, and it’s not a recommendation.